The Eli Lilly logo is shown on one of the company's offices in San Diego, California, September 17, 2020.
Mike Blake | Reuters
A slate of upcoming product launches including an exciting drug for diabetes and weight loss makes Eli Lilly a top pick among pharmaceuticals, according to Morgan Stanley.